Galectin (GALT) Posts Q2 Loss of 17c/Share

Galectin (NASDAQ: GALT) reported Q2 EPS of ($0.17), $0.04 better than the analyst estimate of ($0.21).

For earnings history and earnings-related data on Galectin (GALT) click here.

You May Also Be Interested In

• Nvidia pitches Vera CPU to Chinese clients with August delivery target
• Dollarama Inc. (DOL:CN) (DLMAF) PT Raised to Cdn$221 at BMO Capital
• Barclays Downgrades Travelers (TRV) to Underweight